sun pharma semaglutide receives DCGI approval for generic injection in India Sun Pharmaceutical, Dr. Reddy's Laboratories,

CUSTOMER AGREEMENT: By using and/or purchasing from the Website, User agrees, represents, and warrants that they have conducted their own research, study, and review of the following issues: By purchasing from the Website, User understands and agrees that the Companys products are not offered or sold for human or animal consumption of any kind, type, and methodology, whatsoever

Because absorption differs, oral semaglutide requires careful dosing and timing, and some people experience side effects differently than with injections

Side effects often depend on dose and how quickly the dose increases

The medication is then shipped directly to your home

BioPsychoSocial medicine

Market Analysis: Injection Semaglutide in the Indian Pharmaceutical Market (2026) The Indian pharmaceutical market for Injection Semaglutide has undergone a paradigm shift following the patent expiry on March 20, 2026